Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q (GFM-AZA-REV-09)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01088373
Recruitment Status : Completed
First Posted : March 17, 2010
Last Update Posted : December 15, 2017
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
Groupe Francophone des Myelodysplasies

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 25, 2016
Actual Study Completion Date : July 25, 2016